Literature DB >> 18599741

A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome.

Marc Sultan1, Marcel H Schulz, Hugues Richard, Alon Magen, Andreas Klingenhoff, Matthias Scherf, Martin Seifert, Tatjana Borodina, Aleksey Soldatov, Dmitri Parkhomchuk, Dominic Schmidt, Sean O'Keeffe, Stefan Haas, Martin Vingron, Hans Lehrach, Marie-Laure Yaspo.   

Abstract

The functional complexity of the human transcriptome is not yet fully elucidated. We report a high-throughput sequence of the human transcriptome from a human embryonic kidney and a B cell line. We used shotgun sequencing of transcripts to generate randomly distributed reads. Of these, 50% mapped to unique genomic locations, of which 80% corresponded to known exons. We found that 66% of the polyadenylated transcriptome mapped to known genes and 34% to nonannotated genomic regions. On the basis of known transcripts, RNA-Seq can detect 25% more genes than can microarrays. A global survey of messenger RNA splicing events identified 94,241 splice junctions (4096 of which were previously unidentified) and showed that exon skipping is the most prevalent form of alternative splicing.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599741     DOI: 10.1126/science.1160342

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  617 in total

1.  mRNA-seq with agnostic splice site discovery for nervous system transcriptomics tested in chronic pain.

Authors:  Paul Hammer; Michaela S Banck; Ronny Amberg; Cheng Wang; Gabriele Petznick; Shujun Luo; Irina Khrebtukova; Gary P Schroth; Peter Beyerlein; Andreas S Beutler
Journal:  Genome Res       Date:  2010-05-07       Impact factor: 9.043

2.  Human corin isoforms with different cytoplasmic tails that alter cell surface targeting.

Authors:  Xiaofei Qi; Jingjing Jiang; Mingqing Zhu; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

3.  Estimation of alternative splicing variability in human populations.

Authors:  Mar Gonzàlez-Porta; Miquel Calvo; Michael Sammeth; Roderic Guigó
Journal:  Genome Res       Date:  2011-11-23       Impact factor: 9.043

4.  Intragenic alternative splicing coordination is essential for Caenorhabditis elegans slo-1 gene function.

Authors:  Dominique A Glauser; Brandon E Johnson; Richard W Aldrich; Miriam B Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

5.  Total RNA sequencing reveals nascent transcription and widespread co-transcriptional splicing in the human brain.

Authors:  Adam Ameur; Ammar Zaghlool; Jonatan Halvardson; Anna Wetterbom; Ulf Gyllensten; Lucia Cavelier; Lars Feuk
Journal:  Nat Struct Mol Biol       Date:  2011-11-06       Impact factor: 15.369

6.  Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization.

Authors:  Iouri Chepelev; Gang Wei; Dara Wangsa; Qingsong Tang; Keji Zhao
Journal:  Cell Res       Date:  2012-01-24       Impact factor: 25.617

Review 7.  Molecular diagnostics in transplantation.

Authors:  Maarten Naesens; Minnie M Sarwal
Journal:  Nat Rev Nephrol       Date:  2010-08-24       Impact factor: 28.314

8.  Alternative expression analysis by RNA sequencing.

Authors:  Malachi Griffith; Obi L Griffith; Jill Mwenifumbo; Rodrigo Goya; A Sorana Morrissy; Ryan D Morin; Richard Corbett; Michelle J Tang; Ying-Chen Hou; Trevor J Pugh; Gordon Robertson; Suganthi Chittaranjan; Adrian Ally; Jennifer K Asano; Susanna Y Chan; Haiyan I Li; Helen McDonald; Kevin Teague; Yongjun Zhao; Thomas Zeng; Allen Delaney; Martin Hirst; Gregg B Morin; Steven J M Jones; Isabella T Tai; Marco A Marra
Journal:  Nat Methods       Date:  2010-09-12       Impact factor: 28.547

9.  Statistical design and analysis of RNA sequencing data.

Authors:  Paul L Auer; R W Doerge
Journal:  Genetics       Date:  2010-05-03       Impact factor: 4.562

Review 10.  Oncogenic gene fusions in epithelial carcinomas.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Curr Opin Genet Dev       Date:  2009-02-21       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.